HALO:BMV
Halozyme Therapeutics, Inc.
MX$2,225.00
0.00%
(0.00) 1D
Okt 15, 10:56:30 AM GMT-6 · MXN
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa HALO...
Mkt. cap
13.83B
Avg. na dami
442.00
Dami
0.00
Mataas nang 52-wk
MX$2,225.00
Mababa nang 52-wk
MX$1,126.00
Bilang ng mga empleyado
423
Mkt. cap
13.83B
Avg. na dami
442.00
Dami
0.00
Mataas nang 52-wk
MX$2,225.00
Mababa nang 52-wk
MX$1,126.00
Bilang ng mga empleyado
423
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
10 oras ang nakalipas
H.C. Wainwright reiterates Halozyme stock rating on Takeda trial data
StocksToTrade
·
2 araw ang nakalipas
HALO Stock Climbs As Patent Win And Deals Lift Outlook
Timothy Sykes
·
2 araw ang nakalipas
HALO Stock Climbs As Dutch Court Injunction Lifts Bullish Bets
Simply Wall Street
·
2 araw ang nakalipas
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Tungkol sa Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Mga Empleyado423
Itinatag1998
HeadquartersSan Diego, California, Estados Unidos
Sektor-
Websitehalozyme.com